• Women and men above 40 years of age
• Totally asymptomatic at present
• No prior history of diagnosis or treatment of any cancer
• No clinical or radiological suspicion of cancer at present

A positive Trucheck™ suggests detection of CTCs in the sample, suggesting a higher risk of cancer detection.

Trucheck™ is not intended to be and should not be considered as a replacement for any Standard of Care screening tests.

Within the limits of error, a ‘negative’ result is a reasonable indication of undetectable cancer of the type covered by the test. For other cancers not covered by the test, no inference should be drawn from a ‘negative’ result.

A ‘negative’ results means that at the time of the test there were no detectable cancer cells circulating in the blood.

As Trucheck™ is a non-invasive blood test, there is no disadvantage in frequent testing. However, we advise that Trucheck™ should be performed every 12 months in case of every negative result.

The test indicates the location for the select types of cancers with high accuracy, and in others the Tissue of Origin can be identified with reasonable accuracy. In all cases of ‘positive’ results, our Medical Director will create a personalised care pathway for you for further diagnostic procedures.

No, such individuals should seek expert medical advice without delay.

No.